Skip to content
This is available in:
Global Life Sciences: EU Update

Confirmed: EU Grants Four-Year Transition Period for Certain Low-Risk Devices (Including Software) by Amending EU Medical Devices Regulation

Share

As recently reported (see Sidley Update on the draft Corrigendum No. 2 here), the medtech industry has been eagerly awaiting the second corrigendum to the Medical Devices regulation (MDR). On December 27, 2019, the final version of the second corrigendum to the MDR (Corrigendum No. 2, available here) was published. Sidley prepared a consolidated version of the amended MDR, which can be accessed here.

Attorney Advertising—Sidley Austin LLP is a global law firm. Our addresses and contact information can be found at www.sidley.com/en/locations/offices.

Sidley provides this information as a service to clients and other friends for educational purposes only. It should not be construed or relied on as legal advice or to create a lawyer-client relationship. Readers should not act upon this information without seeking advice from professional advisers. Sidley and Sidley Austin refer to Sidley Austin LLP and affiliated partnerships as explained at www.sidley.com/disclaimer.

© Sidley Austin LLP

Contacts

If you have any questions regarding this Sidley Update, please contact the Sidley lawyer with whom you usually work, or

Offices